Healthtech Startups

Albert Health operates an AI-powered chronic disease management platform that helps patients improve medication adherence and quality of life through personalized, evidence-based guidance. The platform serves patients living with chronic diseases, working with healthcare providers, insurers, and pharmaceutical companies across five countries.

2 investors

A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.

2 investors

Alcon develops eye care products and medical technologies, including the Valeda Photobiomodulation (PBM) system for retina treatment, for eye care professionals such as retina specialists.

2 investors

Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.

2 investors

A senior care consulting firm serving Greater Boston families since 1993, offering life care management and aging support services with clinical expertise in geriatric social work.

2 investors

Aldevron provides products and services for biotechnology research and life sciences discovery, operating as a subsidiary of Danaher to enable breakthrough scientific advances.

2 investors

Alegeus provides a benefit account and payment platform for administrators and partners managing consumer-directed healthcare accounts such as HSAs, FSAs, HRAs, COBRA, commuter, and supplemental benefits programs. It offers software plus outsourced services to help benefit providers administer, scale, and grow their offerings across the healthcare and fintech space.

2 investors

AlemHealth develops hardware and software tools for hospitals and diagnostic centers in emerging markets to deliver radiological imaging services and analysis with minimal requirements for reliable power, internet connectivity, or on-site specialists.

2 investors

Alertgy develops a non-invasive wristband device for real-time blood glucose monitoring in diabetics using Deep-Gluco sensor technology. The product targets both individual patients and healthcare providers.

2 investors

Alethia Biotherapeutics is a clinical-stage biotechnology company developing cancer treatments that target tumor resistance by inhibiting the epithelial-mesenchymal transition (EMT) and remodeling the immunosuppressive tumor microenvironment. Its lead asset, sotevtamab, is a monoclonal antibody intended to be combined with standard therapies across multiple cancer indications.

2 investors

Aleva Neurotherapeutics develops a high-resolution neurostimulation platform that delivers targeted therapy with high selectivity. Its technology is used in the medical device field for precise neural stimulation.

2 investors

Alexza Pharmaceuticals, now operating as Nova Pneuma, Inc., is a pharmaceutical company that developed the Staccato One Breath Technology drug-delivery platform and markets the commercial product Adasuve. Its Staccato platform and assets were acquired by Lee's Pharmaceutical Holdings.

2 investors

Alfadocs is a cloud-based practice management software for Italian healthcare providers, including dental clinics, physiotherapists, aesthetic medicine practices, and multi-specialty outpatient centers. It centralizes scheduling, patient records, digital consent signing, and AI-assisted clinical note-taking.

2 investors

Alfie was an AI-powered clinical decision support platform for obesity and metabolic health management that analyzed patient medical history to recommend evidence-based treatment strategies. The company has been acquired by knownwell and is no longer operating independently.

2 investors

Alia Therapeutics is a biotech company developing therapeutics based on gene-editing technology.

2 investors

Alignment Health provides healthcare services for seniors through a combination of technology and care delivery across multiple channels, including telehealth, in-person doctor visits, and home care.

2 investors

Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.

2 investors

ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.

2 investors

AllerVie Health is a network of board-certified allergists, advanced practice providers, and clinical staff offering allergy, asthma, and immunology diagnostics and treatments to patients across the United States. It also partners with physicians to provide administrative and operational support for their allergy practices and participates in clinical research.

2 investors

AlleyPin is a B2B medical technology provider that builds a LINE-based patient relationship management system (1.Talk) for clinics and healthcare institutions to manage patient interactions, reviews, and clinic operations. Focused on Taiwan's healthcare market, it also offers consulting services to help medical practices adopt digital tools and improve the patient experience.

2 investors

Alliance Animal Health operates a network of 250+ partner veterinary practices across 30 U.S. states, providing animal care services through a decentralized network of independent clinics.

2 investors

A pharmaceutical and life sciences company developing drug pipelines and conducting research and innovation activities. Based in Shanghai, the company focuses on pharmaceutical development and external partnerships in the biotech sector.

2 investors

AllLife provides life insurance coverage designed for people living with HIV, offering lump sum payouts to beneficiaries upon death along with living benefits including emergency ambulance services and medical helpline support. The company operates in South Africa and specializes in making life insurance accessible and affordable for HIV-positive individuals with financial dependents.

2 investors

Allorion Therapeutics is a drug development company focused on advancing new therapeutics. The page presents its leadership and scientific founders drawn from academic and medical research institutions.

2 investors